Liqun Zou

Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial

Yuankai Shi, Hang Su, Yongping Song et al. · The Lancet Haematology · 2019 · 249 citations

Life Sciences, Immunology, Oncology +7

Phase 2 trial of “Sandwich” <scp>L</scp>‐asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T‐cell lymphoma

Ming Jiang, Hong Zhang, Yu Jiang et al. · Cancer · 2011 · 125 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Clinical characteristics of 45 patients with invasive pulmonary aspergillosis

Xi Yan, Mei Li, Ming Jiang et al. · Cancer · 2009 · 92 citations · Full text

Medicine, Oncology, Pathology +14

Cathepsin B as a potential prognostic and therapeutic marker for human lung squamous cell carcinoma

Fengming Gong, Xingchen Peng, Can Luo et al. · Molecular Cancer · 2013 · 64 citations · Full text

Medicine, Molecular Biology, Oncology +17

Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma

Xinhua Wang, Lei Zhang, Xiangli Liu et al. · JAMA Oncology · 2022 · 58 citations · Full text

Medicine, Oncology, Pharmacology +13